Tag Archives: ECYT

Top 10 Heal Care Stocks To Own For 2019

Photo Courtesy of Shutterstock

Welcome to The Salary Chronicles, where we’re bringing transparency to negotiation and salaries, one story at a time. We ask women to share their experiences negotiating their salary and what their advice is for others doing the same. We share these stories anonymously so they feel comfortable speaking as openly and as freely as possible.

This week we’re speaking with a woman who spent two years adding value in her role with her company and used that as the basis to ask for two promotions in two years. 

Original Salary: $50k

Negotiated Salary: $87K

Role: E-commerce Project Manager

Location: Los Angeles

What was the situation?

As my first job out of fashion school, I landed a role with a large, fast paced retailer as a project coordinator. In this role I was tasked with helping teams across the organization tackle issues they were facing.

Top 10 Heal Care Stocks To Own For 2019: CytomX Therapeutics, Inc.(CTMX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of CytomX Therapeutics Inc (NASDAQ:CTMX) have been given a consensus recommendation of “Buy” by the ten ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $38.33.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CytomX Therapeutics (CTMX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'.
    CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss.
    Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session.
    Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading.
    Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
    Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday.
    Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday.
    Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday.
    Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.

     

  • [By Logan Wallace]

    KemPharm (NASDAQ: CTMX) and CytomX Therapeutics (NASDAQ:CTMX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.

  • [By Ethan Ryder]

    CytomX Therapeutics Inc (NASDAQ:CTMX) – Stock analysts at Jefferies Financial Group issued their Q3 2018 EPS estimates for shares of CytomX Therapeutics in a research report issued on Wednesday, August 8th. Jefferies Financial Group analyst B. Amin expects that the biotechnology company will post earnings per share of ($0.57) for the quarter. Jefferies Financial Group also issued estimates for CytomX Therapeutics’ Q4 2018 earnings at ($0.64) EPS, FY2018 earnings at ($1.98) EPS, FY2019 earnings at ($2.73) EPS, FY2020 earnings at ($3.12) EPS, FY2021 earnings at ($3.27) EPS and FY2022 earnings at ($3.33) EPS.

Top 10 Heal Care Stocks To Own For 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By Max Byerly]

    Wall Street analysts expect Bloomin’ Brands Inc (NASDAQ:BLMN) to post earnings of $0.08 per share for the current quarter, Zacks reports. Five analysts have made estimates for Bloomin’ Brands’ earnings. The highest EPS estimate is $0.12 and the lowest is $0.05. Bloomin’ Brands reported earnings of $0.12 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 33.3%. The firm is expected to report its next earnings results on Friday, November 2nd.

  • [By Joseph Griffin]

    Bloomin’ Brands (NASDAQ: BLMN) and Brinker International (NYSE:EAT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

  • [By Max Byerly]

    ILLEGAL ACTIVITY NOTICE: “Bloomin’ Brands (BLMN) Receives $22.63 Consensus Price Target from Analysts” was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3379609/bloomin-brands-blmn-receives-22-63-consensus-price-target-from-analysts.html.

  • [By Logan Wallace]

    These are some of the media stories that may have effected Accern Sentiment’s scoring:

    Get First Majestic Silver alerts:

    Zacks: Analysts Anticipate First Majestic Silver Corp. (AG) Will Announce Earnings of $0.03 Per Share (americanbankingnews.com) News Report of Sizzling Basic materials Stock: First Majestic Silver Corp. (AG) (nasdaqplace.com) Stock in the Wall Street Spotlight: First Majestic Silver Corp. (AG) (nysewired.com) Is the Stock Overvalued? – First Majestic Silver Corp. (NYSE:AG) (nasdaqjournal.com) Stocks in the Spotlight: Oasis Petroleum Inc. (NYSE:OAS), Bloomin’ Brands, Inc. (NASDAQ:BLMN), First Majestic Silver … (journalfinance.net)

    Shares of First Majestic Silver opened at $7.30 on Friday, MarketBeat.com reports. First Majestic Silver has a 12-month low of $4.93 and a 12-month high of $8.73. The company has a market capitalization of $1.41 billion, a P/E ratio of -182.50 and a beta of 0.30. The company has a debt-to-equity ratio of 0.21, a current ratio of 4.41 and a quick ratio of 4.15.

Top 10 Heal Care Stocks To Own For 2019: CYREN Ltd.(CYRN)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Lisa Levin] Companies Reporting Before The Bell
    Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.97 per share on revenue of $2.91 billion.
    Kohl's Corporation (NYSE: KSS) is expected to report quarterly earnings at $0.5 per share on revenue of $3.95 billion.
    The TJX Companies, Inc. (NYSE: TJX) is projected to report quarterly earnings at $1.02 per share on revenue of $8.47 billion.
    AutoZone, Inc. (NYSE: AZO) is estimated to report quarterly earnings at $13.01 per share on revenue of $2.72 billion.
    Dycom Industries, Inc. (NYSE: DY) is projected to report quarterly earnings at $0.7 per share on revenue of $734.86 million.
    Eaton Vance Corp. (NYSE: EV) is estimated to report quarterly earnings at $0.79 per share on revenue of $425.42 million.
    Photronics, Inc. (NASDAQ: PLAB) is expected to report quarterly earnings at $0.07 per share on revenue of $124.17 million.
    Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is estimated to report quarterly earnings at $1.93 per share on revenue of $715.15 million.
    Radcom Ltd. (NASDAQ: RDCM) is expected to post quarterly earnings at $1.96 per share on revenue of $718.59 million.
    Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $718.96 million.
    CYREN Ltd. (NASDAQ: CYRN) is estimated to report quarterly loss at $0.08 per share on revenue of $7.72 million.
    Ferroglobe PLC (NYSE: GSM) is projected to report quarterly earnings at $0.16 per share on revenue of $559.15 million.
    Dr. Reddy's Laboratories Limited (NYSE: RDY) is estimated to report earnings for its fourth quarter.
    BioLineRx Ltd. (NASDAQ: BLRX) is expected to report quarterly loss at $0.07 per share.
    Toll Brothers, Inc. (NYSE: TOL) is estimated to post quarterly earnings at $0.76 per share on revenue of $1.58 billion.

     

  • [By Lisa Levin] Gainers
    Regional Health Properties, Inc. (NYSE: RHE) shares surged 56 percent to $0.3980.
    Precipio, Inc. (NASDAQ: PRPO) shares jumped 34 percent to $0.5632 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.
    SenesTech, Inc. (NASDAQ: SNES) rose 16 percent to $1.45 after trading higher at one point Monday by nearly 300 percent. The nano-cap developer of pest control said the California state government approved the company's ContraPest for user in the state.
    America's Car-Mart, Inc. (NASDAQ: CRMT) gained 13.3 percent to $61.975 after reporting upbeat Q4 results.
    Check-Cap Ltd. (NASDAQ: CHEK) shares gained 9.8 percent to $4.92 as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Arcimoto, Inc. (NASDAQ: FUV) rose 8.3 percent to $3.41.
    Ferroglobe PLC (NYSE: GSM) gained 7 percent to $12.13 following stronger-than-expected quarterly earnings.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 6.5 percent to $9.00 after the company reported upbeat Q2 results.
    Micron Technology, Inc. (NASDAQ: MU) rose 6.2 percent to $58.94 after reporting a $10 billion buyback plan.
    Blink Charging Co. (NASDAQ: BLNK) gained 6.2 percent to $7.53. Blink Charging disclosed that its vehicle charging network exceeds 125,000 members.
    The Container Store Group, Inc. (NYSE: TCS) gained 5.4 percent to $7.97. Container Store is expected to release quarterly earnings after the closing bell.
    Cyren Ltd (NASDAQ: CYRN) shares rose 5.4 percent to $2.95 after reporting Q1 results.

    Check out these big penny stock gainers and losers

Top 10 Heal Care Stocks To Own For 2019: Daily Journal Corp. (S.C.)(DJCO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of Daily Journal (NASDAQ:DJCO) from a buy rating to a hold rating in a research report released on Tuesday.

    Separately, TheStreet raised shares of Daily Journal from a c- rating to a b rating in a report on Monday, February 12th.

Top 10 Heal Care Stocks To Own For 2019: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Brian Orelli]

    Shares of Endocyte (NASDAQ:ECYT) are up 7.5% as of 12:11 p.m. EDT, having been up as much as 18% today, after the biotech released updated data from its phase 2 trial testing 177Lu-PSMA-617. It will be presented at the American Society of Clinical Oncology (ASCO) annual meeting next month.

  • [By Chris Lange]

    Endocyte Inc. (NASDAQ: ECYT) shares made a solid gain early on Monday after the company announced an update from the U.S. Food and Drug Administration (FDA).

  • [By Joseph Griffin]

    Endocyte (NASDAQ:ECYT) is set to release its earnings data after the market closes on Monday, May 7th. Analysts expect Endocyte to post earnings of ($0.19) per share for the quarter.

Top 10 Heal Care Stocks To Own For 2019: Rogers Communication, Inc.(RCI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Rogers Communications Inc. Class B (TSE:RCI.B) (NYSE:RCI) had its target price lifted by National Bank Financial from C$68.00 to C$69.00 in a report issued on Friday morning. The brokerage currently has a sector perform rating on the stock.

  • [By Shane Hupp]

    Rogers Communications (NYSE:RCI) (TSE:RCI.B) announced a quarterly dividend on Friday, April 20th, Wall Street Journal reports. Shareholders of record on Monday, June 11th will be paid a dividend of 0.3821 per share by the Wireless communications provider on Tuesday, July 3rd. This represents a $1.53 dividend on an annualized basis and a yield of 3.27%. The ex-dividend date is Friday, June 8th.

  • [By Max Byerly]

    Media coverage about Rogers Communications Inc. Class B (NYSE:RCI) (TSE:RCI.B) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Rogers Communications Inc. Class B earned a coverage optimism score of 0.08 on Accern’s scale. Accern also assigned media headlines about the Wireless communications provider an impact score of 45.3527592568768 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 10 Heal Care Stocks To Own For 2019: Nestlé S.A. (NSRGF)

Advisors’ Opinion:

  • [By ]

    A year ago July, I recommended ASBFY a BUY along with Nestlé (OTCPK: NSRGY) (OTCPK: NSRGF). Briefly, ASBFY is

    A diversified international food, ingredients and retail group with sales of more than $32.6B operating in 50 countries on six continents Owner of brands including Mazola, Karo Syrup, Fleischmann Yeast, Durkee, Twinings Ovaltine, Tip Top Bakeries and more A huge producer of sugar and bioethanol fuels from China to Spain, and Africa’s largest sugar producer with factories in six countries A supplier of products and tech services to farmers, feed and food manufacturers, processors and retailers A producer of yeast and bakery ingredients operating plants in 32 countries and selling into 92 countries, plus it manufactures and markets enzymes, lipids, yeast extracts, and cereal specialties Primark is the ASBFY signature fashion chain with more than 300 stores in the UK and across Europe that bolsters ASBFY by accounting for half the company’s revenue and profit. Share Price Slump Is An Opportunity

    Shares last July were selling in the $39 range, rose to $45 close to November 2017, then began a slow but steady slide downhill opening August ’18 at just above $31. July 5, ’18 ASBFY announced “group revenue from continuing businesses for the 40 weeks ended 23 June 2018 was 3% ahead of the same period last year at constant currency and 2% ahead at actual exchange rates. Excluding Sugar, sales growth the developed from continuing businesses was 6% ahead of last year at constant currency and 5% ahead at actual exchange rates.” The grocery business pushed ahead 4% in the quarter with margins expected to increase for the full year. Ingredients revenue was up 4% and revenue from agriculture in the third quarter was +12% ahead of last year. Sales at Primark were +6% as sales space expanded.

Top 10 Heal Care Stocks To Own For 2019: SoftBank Group Corp. (SFTBY)

Advisors’ Opinion:

  • [By ]

    Here Are 4 Hot Things to Know About Stocks Right Now Dow Jones futures point to a 281 point drop when markets open. S&P 500 mini futures were down 1.04% and Nasdaq futures were off 1.05%. Action Alerts PLUS holding Facebook (FB) shares are down 1% in premarket trading ahead of CEO Mark Zuckerberg’s second round of in front of U.S. lawmakers. Shares gained 4.5% while he testified in front of the Senate Tuesday.  SoftBank Group Corp. (SFTBY) and Deutsche Telekom AG (DTEGY) , the respective owners of Sprint (S) and T-Mobile US (TMUS) surged on reports of more merger talks. Maybe Trump is right about Action Alerts PLUS holding Amazon (AMZN) : Jefferies estimates that about 62% of Amazons packages flow through the USPS. Via @BrianSozzi Overview

    Wall Street futures were in the red Wednesday, April 11, ahead of key inflation data out of the U.S. expected at 8:30 am ET. Futures fell significantly after President Donald Trump tweeted Wednesday morning telling Russia to “get ready” for Syria Missile Strikes. 

  • [By ]

    Deutsche Telekom will hold 42% of the equity, with Softbank (SFTBY) owning 27% and the remaining 31% to be held by public investors. The new company will take on the T-Mobile name.

  • [By Anders Bylund]

    Altaba recently sold 614 million Yahoo Japan shares to Japanese mobile-network operator SoftBank (NASDAQOTH:SFTBY), reducing its own holdings in that company by 30%. This was the first attempt to turn any of Altaba’s stock holdings into cold, hard cash.

Top 10 Heal Care Stocks To Own For 2019: Adams Diversified Equity Fund, Inc.(ADX)

Advisors’ Opinion:

  • [By Max Byerly]

    AdEx (CURRENCY:ADX) traded up 9.2% against the dollar during the twenty-four hour period ending at 18:00 PM Eastern on April 24th. In the last seven days, AdEx has traded up 47.7% against the dollar. One AdEx token can now be purchased for about $1.12 or 0.00011782 BTC on major cryptocurrency exchanges including IDEX, Huobi, EtherDelta (ForkDelta) and Liqui. AdEx has a total market cap of $81.99 million and approximately $13.84 million worth of AdEx was traded on exchanges in the last day.

  • [By Stephan Byrd]

    AdEx (CURRENCY:ADX) traded 3.5% higher against the U.S. dollar during the twenty-four hour period ending at 18:00 PM Eastern on September 3rd. One AdEx token can currently be bought for $0.22 or 0.00003064 BTC on popular cryptocurrency exchanges including EtherDelta (ForkDelta), Bittrex, IDEX and Upbit. AdEx has a total market cap of $16.37 million and $1.48 million worth of AdEx was traded on exchanges in the last day. Over the last seven days, AdEx has traded 12% higher against the U.S. dollar.

  • [By Shane Hupp]

    AdEx (CURRENCY:ADX) traded 2.3% lower against the U.S. dollar during the 1-day period ending at 15:00 PM E.T. on May 12th. One AdEx token can now be purchased for $0.77 or 0.00009068 BTC on major cryptocurrency exchanges including IDEX, EtherDelta (ForkDelta), Binance and Gatecoin. During the last seven days, AdEx has traded 25.9% lower against the U.S. dollar. AdEx has a total market cap of $56.24 million and $2.87 million worth of AdEx was traded on exchanges in the last day.

  • [By WWW.GURUFOCUS.COM]

    For the details of Candlewood Investment Group, LP’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Candlewood+Investment+Group%2C+LP

    These are the top 5 holdings of Candlewood Investment Group, LPPacific Ethanol Inc (PEIX) – 1,680,130 shares, 100% of the total portfolio. Shares added by 42.52%Adams Diversified Equity Fund Inc (ADX) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%Ambac Financial Group Inc (AMBC) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%JPMorgan Chase Capital XVI JP Morgan Alerian MLP E (AMJ) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%VanEck Vectors Fallen Angel High Yield Bond (ANGL) – 0 shares, 0% of the total portfol

Top 10 Heal Care Stocks To Own For 2019: Oil States International Inc.(OIS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the news articles that may have impacted Accern’s rankings:

    Get Oil States International alerts:

    Oil States Names New Board Chairman To Replace Mark Papa (epmag.com) Oil States chairman Papa resigns, joins Schlumberger’s board (seekingalpha.com) Oil States International chairman resigns, joins Schlumberger's board of directors (finance.yahoo.com) Oil States’ Board Names Robert L. Potter as its New Chairman (finance.yahoo.com) Oil States International, Inc. (OIS) Expected to Announce Quarterly Sales of $284.87 Million (americanbankingnews.com)

    Several equities analysts have commented on OIS shares. ValuEngine cut shares of Oil States International from a “buy” rating to a “hold” rating in a research report on Saturday, June 2nd. Wells Fargo & Co cut shares of Oil States International from an “outperform” rating to a “market perform” rating in a research report on Monday, April 30th. Zacks Investment Research cut shares of Oil States International from a “buy” rating to a “hold” rating in a research report on Wednesday, April 25th. SunTrust Banks set a $32.00 target price on shares of Oil States International and gave the stock a “hold” rating in a research report on Thursday, May 3rd. Finally, Evercore ISI cut shares of Oil States International from an “in-line” rating to an “underperform” rating in a research report on Monday, April 30th. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating and three have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $32.08.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Oil States International (OIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Oil States International (OIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Oil States International (NYSE: OIS) and Newpark Resources (NYSE:NR) are both small-cap oils/energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk.

  • [By Joseph Griffin]

    Oil States International (NYSE: OIS) is one of 14 public companies in the “Oil & gas field machinery” industry, but how does it contrast to its peers? We will compare Oil States International to similar businesses based on the strength of its institutional ownership, profitability, analyst recommendations, valuation, dividends, earnings and risk.

  • [By Stephan Byrd]

    Oil States International (NYSE: OIS) and National-Oilwell Varco (NYSE:NOV) are both oils/energy companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

Top 10 Casino Stocks To Invest In Right Now

The stock market climbed sharply on Thursday, responding well to favorable earnings results from several corners of the market. Major benchmarks were up 1% to 2%, with particularly good performance from the Nasdaq Composite thanks to the tech sector’s outperformance during the day. Yet some stocks suffered from bad news that cast doubt on companies’ ability to benefit from generally favorable business conditions. MGM Resorts International (NYSE:MGM), Arch Coal (NYSE:ARCH), and LendingTree (NASDAQ:TREE) were among the worst performers on the day. Here’s why they did so poorly.

MGM falls despite Cotai opening

Shares of MGM Resorts International lost almost 9% after the company reported its first-quarter financial results. The casino giant said that net revenue was down 1% compared to year-earlier levels, with revenue per available room falling 4.3% at its key Las Vegas Strip properties. Casino revenue was up just 2%, and CEO Jim Murren pointed to the likelihood of continued weakness at Mandalay Bay in the wake of the tragic events that happened there last autumn. Disruptions at Monte Carlo and the cancellation of a major boxing event will also weigh on future results. Even with solid performance from its stake in MGM China, investors aren’t certain that the casino resort operator’s business strategy will yield the results they want to see in the long term.

Top 10 Casino Stocks To Invest In Right Now: Bruker Corporation(BRKR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Bruker (BRKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Bruker (BRKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Invest In Right Now: Peoples Bancorp Inc.(PEBO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Peoples Bancorp (NASDAQ:PEBO) from a strong-buy rating to a buy rating in a report released on Friday.

    Several other equities analysts have also recently issued reports on PEBO. Boenning Scattergood reissued a hold rating on shares of Peoples Bancorp in a research note on Wednesday, April 25th. Hovde Group set a $39.00 price objective on shares of Peoples Bancorp and gave the company a hold rating in a research note on Tuesday, April 24th. Zacks Investment Research raised shares of Peoples Bancorp from a hold rating to a buy rating and set a $37.00 price objective on the stock in a research note on Wednesday, January 10th. ValuEngine raised shares of Peoples Bancorp from a hold rating to a buy rating in a research note on Tuesday, April 24th. Finally, Sandler O’Neill reissued a hold rating and issued a $37.00 price objective on shares of Peoples Bancorp in a research note on Tuesday, January 23rd. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Peoples Bancorp has a consensus rating of Hold and a consensus target price of $38.00.

Top 10 Casino Stocks To Invest In Right Now: Attunity Ltd.(ATTU)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Invest In Right Now: Sandy Spring Bancorp, Inc.(SASR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Sandy Spring Bancorp Inc. (NASDAQ:SASR) Director Mark C. Michael sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, May 18th. The stock was sold at an average price of $41.30, for a total value of $41,300.00. Following the transaction, the director now directly owns 81,590 shares of the company’s stock, valued at $3,369,667. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

  • [By Joseph Griffin]

    LSV Asset Management cut its stake in shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) by 3.4% in the 1st quarter, Holdings Channel reports. The fund owned 92,100 shares of the bank’s stock after selling 3,200 shares during the quarter. LSV Asset Management’s holdings in Sandy Spring Bancorp were worth $3,569,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 Casino Stocks To Invest In Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firms phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

  • [By Brian Orelli]

    Endocyte’s(NASDAQ:ECYT)data from a phase 2 trial testing its prostate cancer drug 177Lu-PSMA-617 showed the drug could lower prostate-specific antigen (PSA), a marker for prostate cancer. Specifically, the drug reduced PSA by at least 50% in 62% of patients and by at least 80% in 44% of patients.

  • [By Joseph Griffin]

    Endocyte (NASDAQ:ECYT) is set to release its earnings data after the market closes on Monday, May 7th. Analysts expect Endocyte to post earnings of ($0.19) per share for the quarter.

Top 10 Casino Stocks To Invest In Right Now: Rockwell Collins, Inc.(COL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Rockwell Collins (COL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s rankings:

    Get Rockwell Collins alerts:

    Military Avionics Systems Market by leading Industry Players (Avidyne, GE Aviation, Honeywell, Rockwell Collins) and Growth Rate (2018-2025) (emailwire.com) Program aims to connect Maryland’s college students and international businesses (msn.com) Rockwell Collins (COL) Expected to Announce Earnings of $1.89 Per Share (americanbankingnews.com) KAI and Rockwell Collins team up for Korean Chinook upgrade (janes.com) German auto giant boosts bet on cutting-edge AR from Silicon Valley (finance.yahoo.com)

    Several research firms have commented on COL. Royal Bank of Canada reiterated a “hold” rating and issued a $143.00 price objective on shares of Rockwell Collins in a report on Friday, April 6th. Zacks Investment Research downgraded shares of Rockwell Collins from a “buy” rating to a “hold” rating in a research note on Thursday, February 22nd. Cowen restated a “hold” rating and issued a $135.00 price target on shares of Rockwell Collins in a research note on Friday, January 26th. Finally, Canaccord Genuity decreased their price target on shares of Rockwell Collins from $140.00 to $137.00 and set a “hold” rating on the stock in a research note on Tuesday, January 30th. Two equities research analysts have rated the stock with a sell rating, seventeen have assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $134.13.

  • [By Lee Samaha]

    Third Point’s first-quarter letter to investors outlined the position in United Technologies and the rationale behind Loeb’s belief that breaking up the company is the best way forward for investors. For reference, the multi-industrial company comprises four segments: Otis elevators; UTC climate controls & security (CCS), specializing in air-conditioning, refrigeration and security; UTC aerospace systems (UTAS); and Pratt & Whitney, maker of aircraft engines. Loeb’s key points are as follows:

    The company’s one-size-fits-all approach has led to a “well-documented history of poor management execution.” A spinoff would create value in the manner of recent precedents in the industrial sector, and allow for more-focused management of the newly created companies. The failure of the market to value United Technologies appropriately to its intrinsic value reflects how investors value aerospace companies (with a long-term perspective, which acceptsnear-term losses on multiyear programs) and multi-industrial companies (by using multiples of next year’s earnings). Shareholders are best served by splitting up the company into three separate ones, specifically Otis; CCS; and an aerospace company built from UTAS, Pratt & Whitney, and the impending acquisition of Rockwell Collins (NYSE:COL).

    To this, I would add that there’s a bewildering number of investment decisions you need to make before buying United Technologies stock right now. For example, you might be worried about growth in construction in China (Otis), or long-term prospects for aerospace suppliers against margin pressure from Boeing and Airbus (UTAS, Rockwell Collins) trying to cut costs or compete directly, or even margin pressure on air-conditioning products (CCS) from rising raw-material costs. All of which give you a good reason not to buy the stock.

  • [By Lee Samaha]

    First, CEO Greg Hayes has promised investors he was looking at strategic options that could be taken after the acquisition of Rockwell Collins (NYSE:COL). As discussed previously, investors need to make a multitude of risk/reward calculations, across all four of its segments, before feeling fully comfortable buying the stock.

Top 10 Casino Stocks To Invest In Right Now: Icahn Enterprises L.P.(IEP)

Advisors’ Opinion:

  • [By ]

    Icahn Enterprises (IEP) : “I don’t really know what they own so I can’t recommend it.”

    Bristol-Myers Squibb (BMY) : “They don’t have what we’re looking for. I’m going to take a pass for the moment.”

  • [By ]

    That being said, Icahn Enterprises (NYSE: IEP) has made the cut on at least three of four of these screens. And since we’re always looking for positive attributes, that bodes well.

  • [By ]

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

  • [By Rich Duprey]

    Icahn Enterprises (NASDAQ:IEP) bought Tropicana in 2008 during the collapse of the financial markets. In 2010, Tropicana emerged from bankruptcy protection under a $200 million deal brokered by Icahn, which gave him control of eight casinos in Indiana, Louisiana, Mississippi, Nevada, Missouri, New Jersey, and Aruba. The Aruba resortis not included in the current deal, but will be sold at a later date.

Top 10 Casino Stocks To Invest In Right Now: J.M. Smucker Company (SJM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on The J.M. Smucker (SJM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephen Mack]

    Everybody knows the ubiquitous Smucker’s brand of fruit spreads. But the 121-year-old Ohio-based J.M. Smucker Co. (NYSE: SJM) is a food conglomerate worth over $12.5 billion. Brands include Jif; several Pillsbury baking products; store-bought coffee brands like Folger’s, Dunkin Donuts, and Caf茅 Bustelo; and some of the top-selling pet foods in the world.

  • [By Stephan Byrd]

    Traders purchased shares of The J.M. Smucker Company (NYSE:SJM) on weakness during trading on Thursday. $66.56 million flowed into the stock on the tick-up and $32.86 million flowed out of the stock on the tick-down, for a money net flow of $33.70 million into the stock. Of all stocks tracked, The J.M. Smucker had the 28th highest net in-flow for the day. The J.M. Smucker traded down ($3.14) for the day and closed at $117.04

  • [By ]

    The packaged food industry has been in a state of flux in recent years, according to Credit Suisse analyst Robert Moskow, as companies like J.M. Smucker Co. (SJM) , Kraft Heinz Co. (KHC) , and others increased their trade spending and made high-priced acquisitions to improve growth rates. 

Top 10 Casino Stocks To Invest In Right Now: Fresh Del Monte Produce, Inc.(FDP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Dean Investment Associates LLC raised its stake in Fresh Del Monte Produce (NYSE:FDP) by 17.9% during the first quarter, HoldingsChannel.com reports. The fund owned 94,185 shares of the company’s stock after acquiring an additional 14,270 shares during the quarter. Dean Investment Associates LLC’s holdings in Fresh Del Monte Produce were worth $4,261,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Fresh Del Monte Produce (NYSE: FDP) and Limoneira (NASDAQ:LMNR) are both consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.

Top 10 Casino Stocks To Invest In Right Now: Patrick Industries, Inc.(PATK)

Advisors’ Opinion:

  • [By Max Byerly]

    News stories about Patrick Industries (NASDAQ:PATK) have trended positive recently, according to Accern Sentiment. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Patrick Industries earned a news sentiment score of 0.36 on Accern’s scale. Accern also gave news articles about the construction company an impact score of 48.3121750669942 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By ]

    LCI Industries (LCII) fell 5% on the day. Patrick Industries Inc. (PATK) dropped 4.24%. Thor Industries Inc. (THO) tanked 9.83%. Winnebago Industries Inc. (WGO) fell 8.85%. 

  • [By Logan Wallace]

    Trexquant Investment LP bought a new stake in shares of Patrick Industries, Inc. (NASDAQ:PATK) in the 1st quarter, HoldingsChannel.com reports. The fund bought 8,360 shares of the construction company’s stock, valued at approximately $517,000.

Top 5 Low Price Stocks To Invest In 2018

Main thesis

I believe that Tuesday Morning (NASDAQ: TUES) is a potential turnaround situation with high upside and limited downside.

Business

According to their 10k,

We are a true closeout retailer, selling high-quality products at prices below those found in boutique, specialty and department stores. Our customers come to us for an ever-changing, exceptional assortment of brand names at great prices. Basically, they purchase items at a very low price from different sources and they sell it below retail.

What makes it interesting

Niche that is likely to be undisturbed by the ecommerce disruption right now Little debt ($30 million from accessing credit facility) with continued access to capital markets Increasing revenue despite industry headwinds, which means that the problem is likely to be internal. Insider buy in Concrete turnaround plan that could work (some of them are already working)

What I think the rest of the market missed

Only 1 analyst covering (according to yahoo finance) Niche presence in a market filled with big names Overall decrease in interest in the traditional brick and mortar retail sector Boring niche with little or no growth

Notable statistics

Top 5 Low Price Stocks To Invest In 2018: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Endocyte (NASDAQ:ECYT) is set to release its earnings data after the market closes on Monday, May 7th. Analysts expect Endocyte to post earnings of ($0.19) per share for the quarter.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firms phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Low Price Stocks To Invest In 2018: H&R Block, Inc.(HRB)

Advisors’ Opinion:

  • [By Chris Lange]

    H&R Block Inc. (NYSE: HRB) is set to release its most recent quarterly results on Tuesday. The consensus forecast calls for a net loss of $1.29 per share and $458.75 million in revenue. Shares closed on Friday at $24.69. The consensus price target is $28.33, and the 52-week range is $20.50 to $31.80.

Top 5 Low Price Stocks To Invest In 2018: PetMed Express, Inc.(PETS)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap pet stockPetmed Express Inc (NASDAQ: PETS) reportedQ3 earnings before the market opened this morning with shares already rising towards a record high on earnings that beat expectationsplus the Companyraised its dividend by 25%. Net sales rose 13.7% to $60.1 millionwhile net income increased 88% to $9.1 million.The CEO commented:

  • [By ]

    Cramer was bearish on PetMed Express (PETS) , Xerox (XRX) , Daseke (DSKE) , Portola Pharmaceuticals (PTLA) , STMicroelectronics (STM) and Booking (BKNG) .

  • [By ]

    PetMed Express (PETS) : “No, no, no, no. When we want pet drugs, we want Idexx Laboratories (IDXX) .”

    Xerox (XRX) : “I’d sell Xerox. That’s a house of pain.”

Top 5 Low Price Stocks To Invest In 2018: H. B. Fuller Company(FUL)

Advisors’ Opinion:

  • [By Max Byerly]

    H.B. Fuller (NYSE: FUL) and CSW Industrials (NASDAQ:CSWI) are both basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Top 5 Low Price Stocks To Invest In 2018: Sherwin-Williams Company (SHW)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Major corporate acquisitions are complicated to work through, and often, surprises come up that prove more costly than anticipated. Paint and coatings manufacturer Sherwin-Williams (NYSE:SHW) has worked long and hard to close on its acquisition of Valspar last year, but even now, there’s work left to do to integrate the two businesses fully to take maximum advantage of their potential synergies.

  • [By Max Byerly]

    Burney Co. decreased its position in Sherwin-Williams (NYSE:SHW) by 2.5% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,064 shares of the specialty chemicals company’s stock after selling 233 shares during the period. Burney Co.’s holdings in Sherwin-Williams were worth $3,554,000 as of its most recent filing with the SEC.

  • [By Motley Fool Staff]

    Sherwin-Williams (NYSE:SHW) Q1 2018 Earnings Conference CallApril 24, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Warren Buffett Stocks To Invest In Right Now

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-927869144&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/927869144/960×0.jpg?fit=scale&q; data-height=&q;768&q; data-width=&q;960&q;&g; Amazon founder and CEO Jeff Bezos (Photo credit: Getty)

While Amazon has been trying to figure out what is causing digital assistant Alexa &l;a href=&q;https://www.nytimes.com/2018/03/08/business/alexa-laugh-amazon-echo.html&q; target=&q;_blank&q;&g;to laugh&l;/a&g; unprompted, founder and CEO Jeff Bezos has been laughing all the way to the bank. His fortune climbed past $130 billion this week.

Bezos&a;nbsp;became $2.1 billion richer on Friday, pushing his net worth to $130.5 billion, as Amazon&s;s stock continues its relentless ascent. Shares have risen 5% in the past week and 85% in the last twelve months. That has quickly made Bezos the richest person on the planet and the first centi-billionaire in the Forbes Billionaire ranks.

The e-commerce king is followed by Bill Gates, the second richest man in the world, who became about $700 million richer on Friday. His net worth: $&l;span&g;92.2 billion.&a;nbsp;&l;/span&g;Legendary investor Warren Buffett rounds out the top three, with a fortune estimated at $&l;span&g;91.3 billion. His net worth swelled by $3.4 billion on Friday.&l;/span&g;

Top 10 Warren Buffett Stocks To Invest In Right Now: Bryn Mawr Bank Corporation(BMTC)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Bryn Mawr Bank (BMTC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks To Invest In Right Now: U.S. Silica Holdings, Inc.(SLCA)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Maxx Chatsko]

    The stock chart says that shares of U.S. Silica Holdings (NYSE:SLCA) have lost one-quarter of their value in 2018 and 47% in the last year alone. The frack sand leader’s operational performance in 2017 says that doesn’t make any sense.

  • [By Joseph Griffin]

    U.S. Silica (NYSE:SLCA) had its price objective trimmed by Morgan Stanley from $47.00 to $43.00 in a report issued on Wednesday. The firm currently has a buy rating on the mining company’s stock.

  • [By Maxx Chatsko]

    Despite posting a sharp recovery in operations in 2017 compared to 2016, frack sand supplier U.S. Silica (NYSE:SLCA) just can’t seem to earn the respect of Wall Street analysts. Shares have fallen 22% in the last year. Some of that is easy to understand considering how badly the company (and the industry as a whole) overshot market demand in the past, which crashed sand prices and wiped out profitability. But I think there’s enough evidence that management has learned valuable lessons and put them into practice this time around.

  • [By Tyler Crowe]

    U.S. Silica Holdings (NYSE:SLCA) has long been the standout company in the frack sand business. Its size and financial strength allowed it to weather the drop in oil prices better than its peers and positioned it well for the recent growth phase. This past quarter, the company expanded its universe by acquiring another mineral mining business, but it is taking some risk in doing this. Thankfully, demand for frack sand remains high, as evidenced by the company’s most recent earnings results.

Top 10 Warren Buffett Stocks To Invest In Right Now: Genesis Energy, L.P.(GEL)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P
  • [By ]

    Genesis Energy LP (NYSE: GEL)
    Billing itself as a “growth-oriented master limited partnership,” GEL concentrates its efforts on providing services around and within refineries primarily located on the Gulf Coast. Management is committed to logical double-digit growth as well as strengthening its distribution coverage. At $20.80 per unit, GEL yields 11.8% and trades at a nearly 40% discount to its 52-week high.

Top 10 Warren Buffett Stocks To Invest In Right Now: Activision Blizzard, Inc(ATVI)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    Activision Blizzard (NASDAQ:ATVI)recently announced earnings results that edged past management’s targets. The video game publisher notched important first-quarter wins in core metrics such as engagement and profitability. However, due to the timing of its biggest releases, and plans to ramp up the esports and advertising businesses, investors won’t have a clear picture on Activision’s 2018 performance until later in the fiscal year than usual.

  • [By John Ballard]

    Activision Blizzard (NASDAQ:ATVI) will announce its first-quarter 2018 earnings on May 3, after the market close.

    The first quarter is typically one of the slowest quarters of the year for video game companies. Activision didn’t have any new releases to start the year, so it will be important to watch how new content updates to existing games performed, most notably for Call of Duty and Overwatch.

  • [By Rich Duprey, Rich Smith, and Travis Hoium]

    Yet Shopify isn’t the only business with compelling arguments in its favor. We asked three of our Motley Fool investors for growth stocks that they like that have the potential to post returns that would put Shopify’s own to shame. They chose gaming specialist Activision Blizzard (NASDAQ:ATVI), electric car maker Tesla (NASDAQ:TSLA), and streaming device maker Roku (NASDAQ:ROKU).

  • [By Motley Fool Staff]

    Stock No. 1: The first one up is Activision Blizzard (NASDAQ:ATVI). ATVI is the ticker symbol. Activision Blizzard is, for me anyway, the worldwide leader. There’s some good competition [Electronic Artsand others] in interactive entertainment.

Top 10 Warren Buffett Stocks To Invest In Right Now: Chunghwa Telecom Co., Ltd.(CHT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News stories about Chunghwa Telecom (NYSE:CHT) have trended positive on Monday, according to Accern Sentiment. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Chunghwa Telecom earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned press coverage about the utilities provider an impact score of 46.731481807669 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top 10 Warren Buffett Stocks To Invest In Right Now: National CineMedia, Inc.(NCMI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    athenahealth, Inc. (NASDAQ: ATHN) shares climbed 23.2 percent to $155.19 after Elliott Management confirmed a $160 per share cash offer for athenahealth.
    Evolus, Inc. (NASDAQ: EOLS) gained 21.3 percent to $8.83. Evolus named David Moatazedi as new CEO.
    VivoPower International PLC (NASDAQ: VVPR) climbed 18.2 percent to $3.12 after falling 39.86 percent on Friday.
    Gramercy Property Trust (NYSE: GPT) rose 15.6 percent to $27.53 after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    EP Energy Corporation (NYSE: EPE) rose 13 percent to $2.26.
    Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) gained 11.9 percent to $7.35.
    National CineMedia, Inc. (NASDAQ: NCMI) surged 11.8 percent to $6.24 after the company posted upbeat quarterly profit.
    Sanchez Energy Corporation (NYSE: SN) shares gained 11.3 percent to $3.56.
    CVR Refining, LP (NYSE: CVRR) shares rose 8.8 percent to $18.875.
    Monaker Group, Inc. (NASDAQ: MKGI) rose 8.7 percent to $2.9683.
    Kosmos Energy Ltd. (NYSE: KOS) shares rose 7.4 percent to $7.40.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 7 percent to $2.88 after climbing 1.89 percent on Friday.
    Cloudera, Inc. (NYSE: CLDR) surged 6 percent to $15.93. Craig-Hallum initiated coverage on Cloudera with a Buy rating.
    Illumina, Inc. (NASDAQ: ILMN) rose 5.1 percent to $257.35. Barclays upgraded Illumina from Equal-Weight to Overweight.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin] Gainers
    Twin Disc, Incorporated (NASDAQ: TWIN) shares surged 24.34 percent to close at $28.86 following Q3 earnings.
    Bioblast Pharma Ltd. (NASDAQ: ORPN) rose 21.89 percent to close at $2.45.
    Evolus, Inc. (NASDAQ: EOLS) gained 20.19 percent to close at $8.75. Evolus named David Moatazedi as new CEO.
    VivoPower International PLC (NASDAQ: VVPR) rose 18.56 percent to close at $3.13 on Monday after falling 39.86 percent on Friday.
    CEL-SCI Corporation (NYSE: CVM) gained 17.09 percent to close at $2.74.
    athenahealth, Inc. (NASDAQ: ATHN) shares jumped 16.39 percent to close at $146.75 on Monday after Elliott Management confirmed a $160 per share cash offer for athenahealth.
    Gramercy Property Trust (NYSE: GPT) rose 15.45 percent to close at $27.50 after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    National CineMedia, Inc. (NASDAQ: NCMI) surged 15.23 percent to close at $6.43 after the company posted upbeat quarterly profit.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 14.53 percent to close at $7.33
    CohBar, Inc. (NASDAQ: CWBR) gained 14.36 percent to close at $6.29.
    Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) gained 12.69 percent to close at $3.64.
    Gannett Co., Inc. (NYSE: GCI) gained 12.27 percent to close at $10.89 following Q1 results.
    CVR Refining, LP (NYSE: CVRR) shares climbed 9.8 percent to close at $19.05.
    Illumina, Inc. (NASDAQ: ILMN) rose 4.93 percent to close at $256.89. Barclays upgraded Illumina from Equal-Weight to Overweight.
    Cloudera, Inc. (NYSE: CLDR) surged 3.92 percent to close at $15.63. Craig-Hallum initiated coverage on Cloudera with a Buy rating.

     

  • [By Stephan Byrd]

    National CineMedia (NASDAQ:NCMI) – Barrington Research lifted their FY2018 earnings per share estimates for National CineMedia in a report released on Monday, May 7th. Barrington Research analyst J. Goss now expects that the business services provider will post earnings of $0.41 per share for the year, up from their previous estimate of $0.34. Barrington Research currently has a “Hold” rating on the stock. Barrington Research also issued estimates for National CineMedia’s Q2 2019 earnings at $0.06 EPS, Q3 2019 earnings at $0.14 EPS and FY2020 earnings at $0.44 EPS.

  • [By Ethan Ryder]

    Shares of National CineMedia (NASDAQ:NCMI) were up 0% during mid-day trading on Tuesday following a stronger than expected earnings report. The company traded as high as $6.59 and last traded at $6.43. Approximately 2,893,100 shares were traded during mid-day trading, an increase of 285% from the average daily volume of 751,461 shares. The stock had previously closed at $6.43.

  • [By Lisa Levin]

    Shares of National CineMedia, Inc. (NASDAQ: NCMI) got a boost, shooting up 16 percent to $6.45 after the company posted upbeat quarterly profit.

    Gramercy Property Trust (NYSE: GPT) shares were also up, gaining 16 percent to $27.52 after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.

Top 10 Warren Buffett Stocks To Invest In Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Endocyte (NASDAQ:ECYT) is set to release its earnings data after the market closes on Monday, May 7th. Analysts expect Endocyte to post earnings of ($0.19) per share for the quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firms phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

Top 10 Warren Buffett Stocks To Invest In Right Now: Axcelis Technologies Inc.(ACLS)

Advisors’ Opinion:

  • [By ]

    3. Axcelis Technologies (Nasdaq: ACLS)
    It is the technical price pattern that first caught my eye with this $800 million market cap small cap. Shares dropped to a $22.00 low in mid-February but have since been slowly and steadily moving higher toward resistance at both the 50- and 200-day SMAs. In and of itself, this is not enough impetus to get long. However, when combined with the fundamental picture, a compelling long thesis emerges.

Top 10 Warren Buffett Stocks To Invest In Right Now: MGM Resorts International(MGM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Sunstone Hotel Investors (NYSE: SHO) and MGM Resorts International (NYSE:MGM) are both finance companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk.

  • [By ]

    The U.S. Supreme Court struck down a law that prohibited New Jersey from allowing sports betting at state casinos, sending gaming sharers higher, including MGM Resorts Int’l (MGM) , Caesars Entertainment (CZR) , and Boyd Gaming (BYD) .

  • [By ]

    Take MGM Resorts (MGM) , a stock that’s soared 58% since Cramer got behind the company nearly two years ago. Shares of MGM rallied from the low $20s to a high of $38 in January, before getting slammed after the company reported earnings last Thursday.

  • [By Travis Hoium]

    Earnings season begins this week, withWynn Resorts, Limited (NASDAQ:WYNN) reporting on Tuesday, April 24, Las Vegas Sands Corp. (NYSE:LVS)on Wednesday, and MGM Resorts International (NYSE:MGM)on Thursday. Caesars Entertainment (NASDAQ:CZR) will report on May 2 with Melco Resorts (NASDAQ:MLCO) to follow later in May.

Top 10 Warren Buffett Stocks To Invest In Right Now: RealPage, Inc.(RP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    RealPage (NASDAQ:RP) had its target price increased by KeyCorp from $61.00 to $65.00 in a research note published on Friday morning. The firm currently has an overweight rating on the software maker’s stock.

-$0.19 Earnings Per Share Expected for Endocyte (ECYT) This Quarter

Analysts predict that Endocyte (NASDAQ:ECYT) will announce earnings per share (EPS) of ($0.19) for the current quarter, Zacks reports. Zero analysts have made estimates for Endocyte’s earnings. The lowest EPS estimate is ($0.25) and the highest is ($0.16). Endocyte reported earnings of ($0.27) per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 29.6%. The firm is scheduled to announce its next quarterly earnings results on Wednesday, May 9th.

According to Zacks, analysts expect that Endocyte will report full-year earnings of ($0.76) per share for the current fiscal year, with EPS estimates ranging from ($0.93) to ($0.70). For the next year, analysts forecast that the company will post earnings of ($0.80) per share, with EPS estimates ranging from ($0.90) to ($0.72). Zacks’ earnings per share averages are a mean average based on a survey of research firms that follow Endocyte.

Get Endocyte alerts:

Endocyte (NASDAQ:ECYT) last released its quarterly earnings results on Monday, February 26th. The biopharmaceutical company reported ($0.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.02). Endocyte had a negative net margin of 78,662.86% and a negative return on equity of 40.33%. The business had revenue of $0.01 million for the quarter. During the same quarter in the prior year, the company earned ($0.26) EPS. The company’s quarterly revenue was up .0% compared to the same quarter last year.

ECYT has been the topic of several recent research reports. BidaskClub upgraded shares of Endocyte from a “buy” rating to a “strong-buy” rating in a research report on Friday. ValuEngine raised shares of Endocyte from a “sell” rating to a “hold” rating in a research note on Wednesday, February 28th. Zacks Investment Research raised shares of Endocyte from a “sell” rating to a “hold” rating in a research note on Friday, February 9th. Cowen raised shares of Endocyte from a “market perform” rating to an “outperform” rating in a research note on Tuesday, February 27th. Finally, Wells Fargo began coverage on shares of Endocyte in a research note on Friday, March 9th. They issued an “outperform” rating for the company. Five research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Endocyte has a consensus rating of “Buy” and an average target price of $9.00.

In other Endocyte news, VP Christopher P. Leamon sold 5,036 shares of the business’s stock in a transaction dated Friday, March 9th. The shares were sold at an average price of $9.07, for a total value of $45,676.52. Following the completion of the transaction, the vice president now directly owns 143,470 shares of the company’s stock, valued at $1,301,272.90. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 14.86% of the company’s stock.

Several large investors have recently modified their holdings of ECYT. Bank of New York Mellon Corp grew its position in shares of Endocyte by 46.5% during the 4th quarter. Bank of New York Mellon Corp now owns 51,313 shares of the biopharmaceutical company’s stock worth $219,000 after buying an additional 16,283 shares during the period. BlackRock Inc. grew its position in shares of Endocyte by 223.7% during the 4th quarter. BlackRock Inc. now owns 1,138,791 shares of the biopharmaceutical company’s stock worth $4,875,000 after buying an additional 786,933 shares during the period. EAM Investors LLC acquired a new stake in shares of Endocyte during the 4th quarter worth approximately $420,000. Geode Capital Management LLC grew its position in shares of Endocyte by 15.6% during the 4th quarter. Geode Capital Management LLC now owns 241,498 shares of the biopharmaceutical company’s stock worth $1,033,000 after buying an additional 32,603 shares during the period. Finally, AXA acquired a new stake in shares of Endocyte during the 4th quarter worth approximately $101,000. Institutional investors own 29.10% of the company’s stock.

NASDAQ ECYT opened at $10.89 on Friday. The firm has a market capitalization of $745.56, a price-to-earnings ratio of -10.89 and a beta of 0.47. Endocyte has a 52-week low of $1.17 and a 52-week high of $11.54.

Endocyte Company Profile

Endocyte, Inc, a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trial to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of advanced solid tumors; and EC1169, a tubulysin therapeutic that is in Phase I dose escalation trial to treat advanced metastatic castration-resistant prostate cancer.

Get a free copy of the Zacks research report on Endocyte (ECYT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Endocyte (NASDAQ:ECYT)

Top Stocks To Watch Right Now

A stock market crash can be devastating to investors with exposure to the stock market. For example, the stock market crash of 2008 caused the Dow Jones Industrial Average (DJIA) to plummet 53% in the 17 months between October 2007 and March 2009.

Those potential losses of more than 50% make learning how to protect your money from a stock market crash essential for every investor.

Must See: This Great Depression-Era “Secret” Helped Transform Two Teachers into Millionaires. Read more…

Today, we’re going to show you how to protect your money with our simple stock market crash protection guide. But before we get to that, we first want to show you what could potentially cause a market crash in 2017…

What Causes a Stock Market Crash?

In the past, risky speculation has pushed stock prices to overinflated highs before stock market crashes.

Take one of the most famous stock market crashes of all time. Speculative investing pushed stock prices to unsustainable highs before the stock market crash of 1929. Stocks skyrocketed during most of the 1920s, with the DJIA rising 300% between 1922 and 1929.

Top Stocks To Watch Right Now: CST Brands, Inc.(CST)

Advisors’ Opinion:

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion. CST Brands shares declined 1.20 percent to close at $36.21 on Thursday.

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

    American Axle & Manufact. Holdings, Inc. (NYSE: AXL) is expected to report its quarterly earnings at $0.71 per share on revenue of $998.76 million.

Top Stocks To Watch Right Now: Cellcom Israel Ltd.(CEL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’ll be listening for news coming from Celgene (CEL) , Amgen (AMGN) , Allergan (AGN) , an Action Alerts PLUS holding, and Regenron (REGN) , all of which are set to present. Of the four, Cramer said he’s sticking with Allergan and Amgen.

Top Stocks To Watch Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firms phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

Top Stocks To Watch Right Now: Vanguard FTSE Europe ETF (VGK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Perhaps the largest ETF dedicated to tracking French stocks should be getting more attention. In a year in which ETFs tracking the PIIGS economies are struggling, EWQ has been solid. The France ETF's 2.7 percent year-to-date gain is slightly ahead of the comparable Germany ETF and more than twice as good as the Vanguard FTSE Europe ETF (NYSE: VGK).

  • [By Todd Shriber, ETF Professor]

    Still, there are instances of limited appetite for diversified Europe ETFs, particularly those with significant U.K. exposure. The Vanguard FTSE Europe ETF (NYSE: VGK) hasn't added (or lost) any capital since June 20. That ETF devotes 31.4 percent of its weight to U.K. stocks.

  • [By Todd Shriber, ETF Professor]

    Here is a dichotomy. Global small-caps are performing admirably. The WisdomTree Europe SmallCap Dividend Fund (NYSE: DFE) is an example of a Europe ETF that is defying some unfavorable trends. DFE is down 3.5 percent year-to-date. That sounds bad, but it is far better than what investors have been treated to with diversified, large-cap Europe ETFs. The Vanguard Europe ETF (NYSE: VGK) and the iShares Europe ETF (NYSE: IEV) are down an average of 5.3 percent this year.

  • [By Tom Aspray, Senior Editor, MoneyShow.com]

    The US stock market is still leading with the Spyder Trust (SPY) up 18.6%, while the European markets (VGK) are now up close to 10% for the year, as they have gotten a nice boost in the past three weeks.

Top Stocks For 2018

The U.S. dollar edged higher against most major currencies Tuesday, getting a break from two sessions of losses as economic data in Europe disappointed and worries about a global trade war eased.

What are currencies doing?

The ICE U.S. Dollar Index
DXY, +0.28%
which measures the bucks performance against six rivals rose 0.4% to 89.379, retracing a 0.5% decline logged Monday, according to FactSet data. The broader WSJ U.S. Dollar Index
BUXX, +0.00%
which measures the greenback against 16 rival currencies, moved up 0.3% to 83.38.

Top Stocks For 2018: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firms phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

Top Stocks For 2018: Great Plains Energy Inc(GXP)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Westar Energy stock declined 8% after regulators at the Kansas Corporation Commissions blocked the sale of Westar to Great Plains Energy (NYSE:GXP). The $12.2 billion merger would have joined utilities in Kansas and Missouri. Great Plains had argued that the combination would produce nearly $2 billion in efficiency gains in the next 10 years, but regulators instead sided with those who had argued that the deal was too rich and would have required rate increases sooner rather than later. Great Plains stock was hardly affected at all by the decision, leading many to conclude that Westar had a lot more to lose from the deal falling through then Great Plains had to gain from a successful merger.

Top Stocks For 2018: Wendy’s/Arby’s Group Inc.(WEN)

Advisors’ Opinion:

  • [By Monica Gerson]

    Wendys Co (NASDAQ: WEN) is expected to report its quarterly earnings at $0.06 per share on revenue of $352.08 million.

    Canadian Solar Inc. (NASDAQ: CSIQ) is estimated to report its quarterly earnings at $0.14 per share on revenue of $663.74 million.

  • [By Monica Gerson]

    Analysts expect Wendys Co (NASDAQ: WEN) to report its quarterly earnings at $0.06 per share on revenue of $352.08 million. Wendys shares rose 1.79 percent to $11.38 in after-hours trading.

  • [By Ben Levisohn]

    Upgrades had a big impact on stocks today. Wendy’s (WEN), for instance, gained 4.5% to $8.62 after being upgraded to Buy at Argus, while Cash America (CSH) advanced 3.7% to $44.32 after being upgraded to Market Outperform from Market Perform at JMP Securities. Walgreen (WAG) proved the big winner in the S&P 500 afterGoldman Sachs called the stock a Conviction Buy.

  • [By Stark Merrifield]

    Bill Ackman: Fifty-year-old Ackmans career began in 1992 when he and fellow Harvard graduate David P. Berkowtiz founded the investment firm Gotham Partners. The firms high-profile bid for Rockefeller Center in New York caused investors to flock to the firm, growing it to $500 million in assets. Then in 2004, with $54 million in personal funding, Ackman started Pershing Square Capital Management. Through Pershing, Ackman bought significant shares in companies like Wendys Co. (Nasdaq: WEN), Target Corp. (NYSE: TGT), Chipotle Mexican Grill Inc. (NYSE: CMG), and Valeant Pharmaceuticals International Inc. (NYSE: VRX). Today, Ackman is worth $1.4 billion and is No. 256 on the Forbes 400.

  • [By Michael Flannelly]

    KeyBanc analysts upgraded fast food restaurant operator The Wendy’s Co (WEN) on Friday, noting that the company has a number of positive developments that could provide a floor for the stock.

    The analysts upgraded WEN from “Underweight” to “Hold.”

    KeyBanc analyst Christopher O’Cull said, “We are raising our rating for The Wendy’s Company to HOLD as we believe: 1) Wendy’s SRS performance will diverge from the industry for the foreseeable future as new products are supported by more effective use of marketing dollars; 2) better menu and promotional management will lead to improved franchisee profitability (a focus of the new CFO Todd Penegor); and 3) the opportunity to extend the re-franchising program will provide a floor on the stock.”

    Wendy’s shares were up 7 cents, or 0.81%, during pre-market trading on Friday. The stock is up 57.01% year-to-date.

  • [By Michael Flannelly]

    Argus Research upgraded fast food restaurant operator The Wendy’s Co (WEN) on Thursday, noting that the company’s store remodeling and new menus should help drive higher sales.

    The analysts upgraded WEN from “Hold” to “Buy” and see shares reaching $10. This price target suggests a 21% upside to the stock’s Wednesday closing price of $8.25.

    Wendy’s shares were up 24 cents, or 2.91%, during early morning trading on Thursday. The stock is up 54.19% year-to-date.